Sharing oncology trial PROs to build the treatment of the future
pharmaphorum
AUGUST 24, 2020
Could collecting, understanding, and disseminating patient-reported outcomes during trials be the key to advancing oncology treatments and improving cancer outcomes? . With our understanding of cancer accelerating at an unprecedented rate, and personalised medicines on the cusp of becoming mainstream, regulatory bodies need new ways to assess products. .
Let's personalize your content